← Evidence map

ArticleFrontiers in pharmacology2024

PCC0208057 as a small molecule inhibitor of TRPC6 in the treatment of prostate cancer.

Yingjie Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38567350